tiprankstipranks
Biocure Technology Inc (TSE:CURE)
CNQX:CURE

Biocure Technology Inc (CURE) Stock News & Sentiment

4 Followers
Biocure Cancels Acquisition of Atriva Therapeutics
PremiumCompany Announcements
Biocure Cancels Acquisition of Atriva Therapeutics
1d ago
Biocure Technology Inc (TSE:CURE) has released an update. Biocure Technology Inc. has announced the mutual termination of its previously planned acquisition of Atriva Therapeutics, with no penalties incurred by either ...Read more
Biocure Delays Transaction Closure with Atriva
PremiumCompany Announcements
Biocure Delays Transaction Closure with Atriva
3M ago

News Score - Last 7 Days

Neutral
TSE:CURE
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average58%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TSE:CURE’s Media Buzz Sentiment?
1 articles about TSE:CURE were published this week. In an average week, 1 articles are published.
    What is TSE:CURE’s weekly average amount of articles?
    In an average week, 1 articles about TSE:CURE are published.
      What is TSE:CURE’s News Sentiment?
      50% of articles about TSE:CURE were positive this week, compared to its sector average of 58%.
        Healthcare Stocks that are Trending in the News
        LBPHLongboard Pharmaceuticals
        CVACCureVac
        CDMOAvid Bioservices
        ELTPElite Pharmaceuticals
        TCNNFTrulieve Cannabis
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis